There was no statistical significance between TROP2 overexpression and sex, age at diagnosis, pathologic T stage, lymph node metastasis, TNM stage, and smoking status (Table 1). This evidence concerns the gene TACSTD2 and metastatic malignant neoplasm in the lymph nodes.